1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
(
- Contribution to journal › Article
- 2016
-
Mark
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
(
- Contribution to journal › Article
- 2014
-
Mark
Classic Bladder Exstrophy: Frequent 22q11.21 Duplications and Definition of a 414 kb Phenocritical Region
(
- Contribution to journal › Article
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
(
- Contribution to journal › Article
- 2013
-
Mark
Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease
(
- Contribution to journal › Article
-
Mark
Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma
(
- Contribution to journal › Article
-
Mark
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
(
- Contribution to journal › Article
-
Mark
The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article